Month: January 2024

Novo Marketing Spend Tops $1B; Obese Subjects in Clinical Trials; Social Isolation and Obesity; Preventing Muscle Mass Loss

Novo Marketing Spend Tops $1B; Obese Subjects in Clinical Trials; Social Isolation and Obesity; Preventing Muscle Mass Loss

January 28, 2024 No Comments

AT A GLANCE The UK’s Daily Mail newspaper notes Novo Nordisk ‘…has spent around $1 billion since 2018 to create the perception that sustained weight loss is only achievable by using the products.’ Scientific American questions if weight-loss drugs are sparking a risky new war on obesity? In counter to recent clinical trials, weight maintenance after stopping GLP-1 drug semaglutide may be possible, as per the Epic Research study.

Read More »
Health-Plans-Expansion-of-Bariatric-Surgery-Transcarent-launches-Comprehensive-Multimodal-Obesity-Care-the-GLP-1-Gold-Rush

Health Plans Expansion of Bariatric Surgery; Transcarent launches Comprehensive Multimodal Obesity Care; the GLP-1 Gold Rush

January 21, 2024 No Comments

AT A GLANCE Modern Healthcare reports ‘…Health insurance companies are expanding their coverage of bariatric surgery amid rising demand for pricey new weight loss drugs.’ Transcarent launches the ‘…First comprehensive Weight Health care experience…’ this week. ‘Drive through GLP-1 providers and the gold rush of companies offering telehealth weight-loss services, in Modern Healthcare. The Ozempic Plateau by Sarah Zhang at The Atlantic NEWS Nona Tepper

Read More »
Bullish-CEOs-at-JP-Morgan-Health-Conference-Nooms-PBM-partnership-FDA-on-Suicidal-Aspects-of-GLP-1-meds-Bariatric-Surgery-Misconceptions

Bullish CEOs at JP Morgan Health Conference; Noom’s PBM partnership; FDA on Suicidal Aspects of GLP-1 meds; Bariatric Surgery Misconceptions

January 14, 2024 No Comments

AT A GLANCE Eli Lilly CEO David Ricks told Yahoo Finance that ‘…a bet on Lilly is to bet we can keep on inventing new things, not just sell the ones we’ve invented.’ Noom announced a partnership with Liviniti, a national pass-through and transparent PBM, for plan sponsors and their employees. Reuters sees pharma execs from Amgen to Pfizer plotting to break into the lucrative obesity

Read More »
LillyDirect for Zepbound; Novo bets on mRNA Drug for Obesity; WW, Noom and Ro run the ‘Obesity Games’ gauntlet; Weight Loss and Work Success.

LillyDirect for Zepbound; Novo bets on mRNA Drug for Obesity; WW, Noom and Ro run the ‘Obesity Games’ gauntlet; Weight Loss and Work Success.

January 7, 2024 No Comments

AT A GLANCE Eli Lilly launches LillyDirect Pharmacy Solutions, with an independent, virtual medical weight-loss clinic, to provide direct consumer access to Zepbound. Novo Nordisk is working with Omega Therapeutics, a start-up from the same stable as moderna, ‘…to develop an mRNA treatment for obesity…’ from STAT News. Rebecca Torrence at Business Insider notes ‘…only a handful of companies have what it takes to make

Read More »
Categories
Archives
Scroll to Top
Skip to content